Specific Incremental Test for Aerobic Fitness in Trail Running: IncremenTrail

Sports (Basel). 2022 Nov 9;10(11):174. doi: 10.3390/sports10110174.

Abstract

Trail running (TR) is performed in a natural environment, including various ranges of slopes where maximal oxygen consumption is a major contributor to performance. The aim of this study is to investigate the validity of tests performed in uphill conditions named the "IncremenTrail" (IncT), based on the incremental ascending speed (AS) to evaluate trail runners' cardiorespiratory parameters. IncT protocol included a constant gradient slope set at 25% during the whole test; the starting speed was 500 m·h-1 (25% slope and 2.06 km·h-1) and increased by 100 m·h-1 every minute (0.41 km·h-1). Twenty trail runner specialists performed the IncT and a supramaximal exercise bout to exhaustion with intensity set at 105% of maximal AS (Tlim). Oxygen consumption, breathing frequency, ventilation, respiratory exchange ratio (RER), and heart rate were continuously recorded during the exercises. The blood lactate concentration and rate of perceived exertion were collected at the end of the exercises. During the IncT test, 16 athletes (80%) reached a plateau of maximal oxygen uptake (65.5 ± 7.6 mL·kg-1·min-1), 19 athletes (95%) reached RER values over 1.10 (1.12 ± 0.02) and all the athletes achieved blood lactate concentration over 8.0 mmol·L-1 (17.1 ± 3.5 mmol·L-1) and a maximal heart rate ≥90% of the theoretical maximum (185 ± 11 bpm). Maximal values were not significantly different between IncT and Tlim. In addition, ventilatory thresholds could be determined for all runners with an associated AS. IncT provided a suitable protocol to evaluate trail runners' cardiorespiratory limitations and allowed us to obtain specific intensities based on the ascending speed useful for training purposes in specific conditions.

Keywords: method; oxygen consumption; testing; trail running; uphill; validation.

Grants and funding

The authors did not receive any money to perform this study.